Get the Stockscreener App
0.5687
2.10%
-0.0122
After Hours:
.57
0.0013
+0.23%
Tilray Brands Inc stock is traded at $0.5687, with a volume of 20.43M.
It is down -2.10% in the last 24 hours and up +34.89% over the past month.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. USA exposure consists of CBD products and alcohol.
See More
Previous Close:
$0.5809
Open:
$0.56
24h Volume:
20.43M
Relative Volume:
0.65
Market Cap:
$573.92M
Revenue:
$829.22M
Net Income/Loss:
$-248.96M
P/E Ratio:
-1.8957
EPS:
-0.3
Net Cash Flow:
$-92.10M
1W Performance:
-17.40%
1M Performance:
+34.89%
6M Performance:
-45.84%
1Y Performance:
-71.42%
1-Day Range:
$0.551
$0.6207
1-Week Range:
$0.551
$0.7092
52-Week Range:
$0.3507
$1.98
Tilray Brands Inc Stock (TLRY) Company Profile
Name
Tilray Brands Inc
Sector
Phone
519.322.8800
Address
655 MADISON AVENUE, NEW YORK
Compare TLRY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TLRY
Tilray Brands Inc
|
0.5687 | 638.13M | 829.22M | -248.96M | -92.10M | -0.30 |
|
ZTS
Zoetis Inc
|
147.38 | 64.91B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.16 | 43.33B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.66 | 42.36B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
15.38 | 17.72B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
294.28 | 12.42B | 2.99B | 1.21B | 1.13B | 25.06 |
Tilray Brands Inc Stock (TLRY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-05-24 | Reiterated | Alliance Global Partners | Neutral |
| Nov-02-22 | Initiated | Bernstein | Mkt Perform |
| Jul-29-22 | Downgrade | The Benchmark Company | Hold → Sell |
| Mar-04-22 | Upgrade | Canaccord Genuity | Hold → Buy |
| Nov-18-21 | Initiated | Barclays | Underweight |
| Nov-01-21 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jun-11-21 | Downgrade | CIBC | Sector Outperform → Neutral |
| Jun-03-21 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| May-11-21 | Resumed | Cowen | Outperform |
| May-07-21 | Resumed | Jefferies | Buy |
| May-06-21 | Initiated | Canaccord Genuity | Buy |
| Apr-28-21 | Resumed | BofA Securities | Buy |
| Feb-18-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Feb-18-21 | Downgrade | The Benchmark Company | Buy → Hold |
| Nov-16-20 | Downgrade | Jefferies | Hold → Underperform |
| Nov-11-20 | Downgrade | Stifel | Hold → Sell |
| Oct-01-20 | Reiterated | MKM Partners | Neutral |
| Sep-21-20 | Upgrade | Jefferies | Underperform → Hold |
| May-12-20 | Reiterated | The Benchmark Company | Buy |
| Apr-16-20 | Downgrade | Jefferies | Hold → Underperform |
| Apr-09-20 | Downgrade | Consumer Edge Research | Overweight → Equal Weight |
| Feb-24-20 | Downgrade | Cowen | Outperform → Market Perform |
| Jan-13-20 | Initiated | BofA/Merrill | Neutral |
| Nov-13-19 | Reiterated | The Benchmark Company | Buy |
| Nov-05-19 | Initiated | Cantor Fitzgerald | Neutral |
| Oct-22-19 | Reiterated | Piper Jaffray | Overweight |
| Sep-20-19 | Initiated | MKM Partners | Neutral |
| Aug-14-19 | Reiterated | The Benchmark Company | Buy |
| Jul-17-19 | Initiated | Ladenburg Thalmann | Neutral |
| Jun-28-19 | Initiated | Consumer Edge Research | Overweight |
| Jun-06-19 | Initiated | Stifel | Hold |
| Jun-05-19 | Initiated | Oppenheimer | Perform |
| May-15-19 | Upgrade | BMO Capital Markets | Underperform → Market Perform |
| May-13-19 | Initiated | Alliance Global Partners | Neutral |
View All
Tilray Brands Inc Stock (TLRY) Latest News
Earnings live: Amazon stock slides, with results from Palantir, McDonald's, Disney, and Uber up ahead - Yahoo Finance
Tilray Brands (NASDAQ:TLRY) Stock Price Down 2.6%Here's Why - MarketBeat
Is Tilray Brands Inc. stock overvalued or undervaluedBest Dividend Tips With High Returns - jammulinksnews.com
Should You Buy, Hold or Sell TLRY Stock Post Q4 Earnings Release? - The Globe and Mail
Why Tilray Stock Was Diving This Week - Nasdaq
Atb Cap Markets Weighs in on Tilray Brands Q1 Earnings - MarketBeat
Tilray Brands proposes reverse stock split - MSN
Brokerages Set Tilray Brands, Inc. (NASDAQ:TLRY) Price Target at $1.92 - MarketBeat
How does Tilray Brands Inc. compare to its industry peersExpert Picks Review For Smart Trading - jammulinksnews.com
Today's SEC FilingsLatest 10-K, 10-Q, 8-K Forms - Stock Titan
Tilray Brands (NASDAQ:TLRY) Shares Down 1%Time to Sell? - MarketBeat
Tilray Brands Reports Growth in Cannabis and Beverage Segments - MSN
Tilray Brands (NASDAQ:TLRY) Shares Down 11.8%Here's What Happened - MarketBeat
What are Tilray Brands Inc. company’s key revenue driversBeginner Investor Guidance For 2025 - jammulinksnews.com
Should I hold or sell Tilray Brands Inc. stock in 2025Post Market Opportunities With High Returns - jammulinksnews.com
Tilray Brands, Inc. Stock (TLRY) Opinions on Q4 Earnings Report - Quiver Quantitative
Tilray Reports Fourth Quarter and Fiscal 2025 Financial Results - mg Magazine
Tilray price target chopped at Roth Capital - Cantech Letter
$80 Bn Medical Marijuana Markets - GlobeNewswire Inc.
Atb Cap Markets Weighs in on Tilray Brands Q4 Earnings - MarketBeat
FY2026 EPS Estimates for Tilray Brands Increased by Analyst - MarketBeat
Is Tilray Brands a Dirt Cheap Growth Stock or Just a Bad Buy? - AOL.com
2 Surging Stocks That You'll Want to Think Twice About Buying Today - Nasdaq
Tilray Brands' (TLRY) "Neutral" Rating Reaffirmed at Zelman & Associates - MarketBeat
Irwin D. Simon Buys 165,000 Shares of Tilray Brands, Inc. (NASDAQ:TLRY) Stock - MarketBeat
Tilray brands CEO Simon Irwin D buys $100k in shares - Investing.com Nigeria
Tilray Brands Executives Make Significant Stock Purchases - TradingView
Carl A. Merton Purchases 33,500 Shares of Tilray Brands, Inc. (NASDAQ:TLRY) Stock - MarketBeat
Tilray Brands (NASDAQ:TLRY) Posts Earnings Results, Beats Expectations By $0.05 EPS - MarketBeat
Tilray Brands (NASDAQ:TLRY) Trading Up 5.4%Here's Why - MarketBeat
Tilray Beverage Biz Posts $241M in Revenue for FY25; Company Records $1.4B Non-Cash Impairment - Brewbound
Tilray Brands, Inc. (NASDAQ:TLRY) Q4 2025 Earnings Call Transcript - Insider Monkey
Tilray Brands Full Year 2025 Earnings: Misses Expectations - Yahoo Finance
Tilray Stock (TLRY): Q4 Results Weigh on Future Prospects - Value The Markets
Tilray Brands 2025 Q4 Earnings Mixed Results as Net Income Declines 8146.5% - AInvest
Tilray Brands Reports In-Line Q4-2025 And FY2025 Results Amidst Weakening Sector - Seeking Alpha
Tilray Brands shares rise 1.04% after-hours following Q4 2025 earnings call. - AInvest
Earnings live: Starbucks posts another US sales decline, Novo stock plunges, Big Tech giants on deck - Yahoo Finance
Why Tilray Stock Burned Out Today - MSN
Tilray Brands (NASDAQ:TLRY) Shares Gap DownHere's What Happened - MarketBeat
Tilray sends pot stocks lower after Q4 results - MSN
Tilray Earnings: Strategic Moves Offer Some Help to Challenged Cannabis, but Alcohol Struggles - Morningstar
Tilray sends pot stocks lower after Q4 results (TLRY:NASDAQ) - Seeking Alpha
Following Mixed Q4 Results, Tilray's Turnaround Strategy Is Put To The Test - Benzinga
Earnings live: Spotify, Novo, UnitedHealth stocks slide after results; Boeing beats - Yahoo Finance
Tilray Plummets With $1.27B Q4 Net Loss Due To 2021 Aphria Merger - thedeepdive.ca
Cannabis Pharmaceuticals Market Report 2025-2029 and 2034 Featuring Leading PlayersCuraleaf, Aphria, Green Thumb Industries, Trulieve Cannabis Corp, and Tilray - Yahoo Finance
Tilray Brands Plunges 10.86% on Mixed Earnings - AInvest
Tilray Brands, Inc. SEC 10-K Report - TradingView
Biggest stock movers Tuesday: TLRY, PHG, and more (NYSE:PHG) - Seeking Alpha
Order Book Volume Tilts Bullish on Tilray Brands Inc.Risk Adjusted Technical Entry Plan Gains Followers - metal.it
Tilray Brands Inc Stock (TLRY) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.87%
0.80%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):